This company has been marked as potentially delisted and may not be actively trading. Hudson Executive Investment (HEC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock HEC vs. KDLY, BTTX, UPHL, SNDL, ERAS, DCTH, CMPX, AQST, EBS, and ITOSShould you be buying Hudson Executive Investment stock or one of its competitors? The main competitors of Hudson Executive Investment include Kindly MD (KDLY), Better Therapeutics (BTTX), UpHealth (UPHL), SNDL (SNDL), Erasca (ERAS), Delcath Systems (DCTH), Compass Therapeutics (CMPX), Aquestive Therapeutics (AQST), Emergent Biosolutions (EBS), and iTeos Therapeutics (ITOS). These companies are all part of the "medical" sector. Hudson Executive Investment vs. Its Competitors Kindly MD Better Therapeutics UpHealth SNDL Erasca Delcath Systems Compass Therapeutics Aquestive Therapeutics Emergent Biosolutions iTeos Therapeutics Hudson Executive Investment (NASDAQ:HEC) and Kindly MD (NASDAQ:KDLY) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment. Do insiders and institutionals believe in HEC or KDLY? 73.4% of Hudson Executive Investment shares are owned by institutional investors. 50.5% of Kindly MD shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has stronger earnings and valuation, HEC or KDLY? Kindly MD has higher revenue and earnings than Hudson Executive Investment. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHudson Executive InvestmentN/AN/A-$27.24MN/AN/AKindly MD$2.47M26.69-$4.64M-$0.77-14.22 Is HEC or KDLY more profitable? Kindly MD's return on equity of 0.00% beat Hudson Executive Investment's return on equity.Company Net Margins Return on Equity Return on Assets Hudson Executive InvestmentN/A -337.48% -4.06% Kindly MD N/A N/A N/A Does the media prefer HEC or KDLY? In the previous week, Kindly MD had 1 more articles in the media than Hudson Executive Investment. MarketBeat recorded 1 mentions for Kindly MD and 0 mentions for Hudson Executive Investment. Kindly MD's average media sentiment score of 1.10 beat Hudson Executive Investment's score of 0.00 indicating that Kindly MD is being referred to more favorably in the news media. Company Overall Sentiment Hudson Executive Investment Neutral Kindly MD Positive SummaryKindly MD beats Hudson Executive Investment on 7 of the 8 factors compared between the two stocks. Get Hudson Executive Investment News Delivered to You Automatically Sign up to receive the latest news and ratings for HEC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HEC vs. The Competition Export to ExcelMetricHudson Executive InvestmentHealth Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$107.64M$71.21M$5.49B$9.45BDividend YieldN/AN/A4.01%4.03%P/E RatioN/AN/A28.4719.90Price / SalesN/A9.69410.1985.18Price / CashN/A4.0235.9658.29Price / Book21.671.158.365.67Net Income-$27.24M-$30.80M$3.24B$258.18M Hudson Executive Investment Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HECHudson Executive InvestmentN/A$2.60+2.0%N/A+19.2%$107.64MN/A0.00N/AKDLYKindly MDN/A$12.09-1.7%N/A+266.2%$72.81M$2.47M-15.70N/APositive NewsBTTXBetter TherapeuticsN/A$0.00flatN/AN/A$5KN/A0.0040UPHLUpHealthN/A$0.00flatN/A-99.9%$4K$130M0.001,750SNDLSNDL1.2778 of 5 stars$1.51-4.4%$3.63+140.1%-27.8%$415.19M$671.81M-5.212,516ERASErasca2.1571 of 5 stars$1.41-3.4%$4.57+224.2%-46.5%$413.60MN/A-2.27120DCTHDelcath Systems2.1518 of 5 stars$11.02-7.2%$24.00+117.8%+33.2%$413.39M$37.21M-22.0460News CoverageHigh Trading VolumeCMPXCompass Therapeutics2.2876 of 5 stars$2.98+2.1%$12.67+325.1%+207.0%$403.79M$850K-7.2720AQSTAquestive Therapeutics1.3036 of 5 stars$4.02-0.2%$10.14+152.3%+31.0%$400.29M$54.23M-6.81160EBSEmergent Biosolutions3.9109 of 5 stars$6.94-5.0%$14.33+106.6%-37.6%$396.23M$1.04B-2.562,420ITOSiTeos Therapeutics3.4292 of 5 stars$10.31-0.4%$15.86+53.8%-38.7%$396.13M$35M-3.3990Trending NewsAnalyst Forecast Related Companies and Tools Related Companies Kindly MD Alternatives Better Therapeutics Alternatives UpHealth Alternatives SNDL Alternatives Erasca Alternatives Delcath Systems Alternatives Compass Therapeutics Alternatives Aquestive Therapeutics Alternatives Emergent Biosolutions Alternatives iTeos Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HEC) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hudson Executive Investment Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hudson Executive Investment With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.